Investing.com-- At least five companies from mainland China and Hong Kong are planning IPOs, dual listings, or share placements on the Singapore Exchange (SGX: SGXL ) over the next 12 to 18 months, Reuters reported on Sunday, citing sources with direct knowledge.

The firms, spanning energy, healthcare, and biotech, are looking to expand their presence in Southeast Asia amid U.S.-China trade tensions, the report said.

The move could revitalize SGX, which hosted only four IPOs in 2024, compared to 71 in Hong Kong, the Reuters report stated.

Growing trade friction with the U.S. has pushed Chinese companies to seek more neutral markets, with listing inquiries rising on the SGX following the latest tariffs, Reuters reported.

SGX recently introduced measures, including a 20% tax rebate for primary listings, to attract more issuers.

While Singapore may not yet rival Hong Kong’s listing scale, its neutrality and regional access are gaining favor among Chinese firms navigating global uncertainty, the report said.